Simultaneous determination of lamotrigine and its glucuronide and methylated metabolites in human plasma by automated sequential trace enrichment of dialysates and gradient high-performance liquid chromatography.
The use of the system, automated sequential trace enrichment of dialysates (ASTED), to prepare plasma samples for the estimation of lamotrigine, its glucuronide and methylated metabolites in plasma prior to gradient high-performance liquid chromatography (HPLC) is described. Using this technique the procedure was observed to be specific for all three compounds and linear over the range 0.04 to 10 microg/ml for lamotrigine and the glucuronide metabolite and 2 to 500 ng/ml for the methylated metabolite. The within-run precision (C.V.) at four different supplemented plasma lamotrigine concentrations of 0.04, 0.10, 2.5 and 10.0 microg/ml was 6.21, 5.17, 1.29 and 0.73%, respectively, and the between-run precision (C.V.) estimated to be 13.49, 6.08, 1.95 and 1.78%, respectively. The overall accuracy (% bias) of the procedure was estimated to be 12.50, 0.00, 2.80 and 1.80%, respectively. The glucuronide and methylated metabolites in plasma showed similar assay performance.
Cooper
J D
JD
Clinical Innovations Ltd., Kenilworth, Warwickshire, UK.
Shearsby
N J
NJ
Taylor
J E
JE
Fook Sheung
C T
CT
D000927:Anticonvulsants / Q000097:blood* / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid / Q000295:instrumentation / Q000379:methods*; D002940:Circadian Rhythm; D004355:Drug Stability; D006801:Humans; D000077213:Lamotrigine; D016014:Linear Models; D015203:Reproducibility of Results; D014227:Triazines / Q000097:blood* / Q000378:metabolism*
D000927:Anticonvulsants; D014227:Triazines; D000077213:Lamotrigine